Lilly receives FDA Fast Track designation for tirzepatide for the treatment of adults with obesity,…
Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the investigation of tirzepatide for the treatment of adults with…
Read More...
Read More...
